<?xml version="1.0" encoding="UTF-8"?>

<article>
<meta-data>
<journal-meta>
<journal-name>Journal of Infectious Diseases and Epidemiology</journal-name>
<journal-shortname>J Infect Dis Epidemiol</journal-shortname>
<journal-doi>10.23937/2474-3658</journal-doi>
<issn>2474-3658</issn>
<publisher>
<publisher-name>ClinMed International Library</publisher-name>
<publisher-location>Wilmington, USA</publisher-location>
<publisher-doi-prefix>10.23937</publisher-doi-prefix>
</publisher>
</journal-meta>
<article-meta>
<article-title>
Seropositivity of Anti-CMV IgM Antibody among Women of Child-Bearing Age Attending Selected Hospitals in Kaduna State, Nigeria
</article-title>
<citation_author>Garba AZ</citation_author>
<article-doi>10.23937/2474-3658/1510315</article-doi>
<article-description>
Human Cytomegalovirus is one of the most common cause of congenital viral infections. The study was conducted to determine the seroprevalence of Human Cytomegalovirus among women of child-bearing age attending selected hospitals in Kaduna State, Nigeria. A total of 228 blood samples were obtained from the women and processed serologically using Enzyme Linked Immunosorbent Assay (ELISA). 
</article-description>
</article-meta>
</meta-data>
<body>
<article-type>Original Article</article-type>
<volume>10</volume>
<issue>2</issue>
<access-type>OPEN ACCESS</access-type>
<article-doi>10.23937/2474-3658/1510315</article-doi>
<article-title>
Seropositivity of Anti-CMV IgM Antibody among Women of Child-Bearing Age Attending Selected Hospitals in Kaduna State, Nigeria
 
</article-title>
<Author-Group>
<aut id="aut1">
<label>Author-1</label>
<name>Anchau Zainab Garba</name>
<affiliation>
Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Kaduna State, Nigeria
</affiliation>
</aut>
<aut id="aut2">
<label>Author-2</label>
<name>Suleiman Ahmad Babangida</name>
<affiliation>
Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Kaduna State, Nigeria
</affiliation>
</aut>
<aut id="aut3">
<label>Author-3</label>
<name>Olonitola O Stephen</name>
<affiliation>
Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Kaduna State, Nigeria
</affiliation>
</aut>
<aut id="aut4">
<label>Author-4</label>
<name>Kwanashie Clara N</name>
<affiliation>
Department of Veterinary Microbiology, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Kaduna State, Nigeria
</affiliation>
</aut>
</Author-Group>
<author-notes>
<corres-author>
<label>Corresponding-Author</label>
<name>Zainab Garba Anchau</name>
<address>
 Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Kaduna State, Nigeria, Tel: +2347030412200.
</address>
</corres-author>
</author-notes>
<history>
<published-date>
<day>11</day>
<month>February  </month>
<year>2024</year>
</published-date>
</history>
<citation>
<author-names>
Garba AZ, Babangida SA, Stephen OO, Clara K
</author-names>
<published-year>2024</published-year>
<article-title>
Seropositivity of Anti-CMV IgM Antibody among Women of Child-Bearing Age Attending Selected Hospitals in Kaduna State, Nigeria
</article-title>
<journal-short-name>J Infect Dis Epidemiol</journal-short-name>
<article-doi>10.23937/2474-3658/1510315</article-doi>
</citation>
<permissions>
<copyright>
<copyright-year>2024</copyright-year>
<copyright-holder>Garba AZ, et al. </copyright-holder>
<copyright-notes>
© This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
</copyright-notes>
</copyright>
</permissions>
<article-content>

<Abstract>
<p>
	
	
	Human Cytomegalovirus is one of the most common cause of congenital viral infections. The study was conducted to determine the seroprevalence of Human Cytomegalovirus among women of child-bearing age attending selected hospitals in Kaduna State, Nigeria. A total of 228 blood samples were obtained from the women and processed serologically using Enzyme Linked Immunosorbent Assay (ELISA). In addition, structured questionnaire was used to determine socio-demographic and risk factors associated with Human Cytomegalovirus infection. Out of the 228 women, 215 (94.3%) were positive for anti-CMV IgM. The highest seroprevalence was observed among women belonging to age group 15-24 (98.8%), those with secondary level of education (98%), those living in the urban areas (95%), the civil servants (100%), the married (94.2%) and those of medium socioeconomic status (94.9%). A statistical significant difference was observed between the age groups only (p = 0.000). With respect to risk factors, female patients; with no sex partners (100%), with history of blood transfusion (96.7%), who do not wash their hands with soap after changing baby's diaper (95.5%), who wash their hands after contact with children's urine (94.7%) and those in close contact with children had highest seroprevalence (94.4%). No statistical significant association was observed between Human Cytomegalovirus infection and the risk factors considered. Female patients should be educated on the transmission routes as well as preventive measures of Human cytomegalovirus infections.
</p></Abstract>
<Keywords>
<p>
	
	
	Seropositivity, Anti-CMV IgM, Child-bearing age women, Kaduna
</p></Keywords>
<Introduction>
<p>
	
	
	Congenital infections are significant cause of perinatal morbidity and mortality estimated to be responsible for up to 50% of stillbirths in low and middle income countries and 10-25% in high income countries [1]. Human Cytomegalovirus (HCMV), an ubiquitous herpes virus with the highest morbidity and mortality compared to other herpes viruses [2] is one of the most common cause of congenital anomaly. The incidence of congenital Human Cytomegalovirus infection has increased by nearly 300% since the early 2000s [3].
</p>
<p>
	Maternal HCMV infection could result to bad pregnancy outcome including abortion, premature delivery, stillbirth and congenital malformation [4,5]. Sexual activity and contact with young children are the main sources of primary maternal HCMV infection (Fowler and Pass, 2006). Primary HCMV infection occurs in 0.7-4.1% of all pregnancies [6]. About 32% of women with primary infection during pregnancy, transmit the virus across the placenta to produce intrauterine infection [7].
</p>
<p>
	Human Cytomegalovirus is the most common infectious cause of fetal malformations [8]. Congenital HCMV affects one in every 150 live births globally [9]. Approximately 7 to 10% of infants with congenital HCMV develop clinical manifestations. These include petechiae, jaundice, hepatosplenomegaly, chorioretinitis as well as neurological deficits, which consists of physical and mental retardation, deafness, and even death in about 10% of patients [10-12].
</p>
<p>
	Factors associated with Human Cytomegalovirus infection include age, socioeconomic status, exposure to young children, race/ethnicity [8,13-15]. In addition, increasing number of live births, early sexual debut, &#38;ge; 10 life time sexual partners, and herpes type II seropositivity also predispose one to HCMV infection [15].
</p>
<p>
	Despite the fact that most women of reproductive age in developing countries are assumed to have immunity against HCMV because of the high seroprevalence, the prevalence of congenital HCMV is still higher in developing countries. Most previous studies on HCMV were conducted on pregnant women and that necessitate the need to include non-pregnant women of reproductive age since maternal HCMV infection can occur prior to or during pregnancy.
</p></Introduction>
<Objectives-of-the-Study>
<p>
	
	
	To determine the seroprevalence of anti-CMV IgM using Enzyme Linked Immunosorbent Assay (ELISA).
</p>
<p>
	To determine socio-demographic and risk factors associated with Human Cytomegalovirus infection using structured questionnaire.
</p></Objectives-of-the-Study>
<Methodology>
<p>
	
	
	Study area
	
	The study was conducted in Kaduna State, which is found in Northern part of Nigeria. Kaduna State is a cosmopolitan state owing to the various educational institutions, research institutes and other governmental and non-governmental parastatals situated which attract people from different parts of the country. The state is divided into three senatorial zones; North zone, Central zone and South zone. The hospitals selected include: Hajiya Gambo Sawaba General Hospital in Zaria from North zone, Yusuf Dantsoho Memorial Hospital in Kaduna metropolis from Central zone and Sir Patrick Ibrahim Yakowa General Hospital Kafanchan from South zone.
</p>
<p>
	Study design
	
	The study is a hospital-based, cross-sectional and descriptive research aimed at women of child-bearing age between the ages of 15-50 years attending Hajiya Gambo Sawaba General Hospital Zaria, Yusuf Dantsoho memorial Hospital, Kaduna and Sir Patrick Ibrahim Yakowa General Hospital, Kafanchan.
</p>
<p>
	Ethical approval and informed consent
	
	Ethical clearance was obtained from the Research Ethics committee of Kaduna State Ministry of Health. Permission to conduct research was sought from the Management of the respective study hospitals. In addition, informed consent of the patients was sought for participation in the study.
</p>
<p>
	Sample size determination
	
	The sample size of the study was determined using a previous prevalence of 94.8% [16] for Human Cytomegalovirus in Kaduna state. The formula described by Naing, et al. [17] was employed. Seventy-six samples were collected from each of the study hospital.
</p>
<p>
	Questionnaire administration and sample collection
	
	Structured questionnaire was administered to the patients to determine socio-demographic and risk factors associated with Human Cytomegalovirus infection. Two milliliters of blood were collected from the patients using a sterile syringe and transferred into plain tubes. The blood samples were transported in insulated cooler containing ice packs to the Laboratory of Department of Microbiology, Ahmadu Bello University, Zaria for analysis. The blood samples were processed according to the method described by Umeh, et al. [18]. Sera from the blood samples were separated by allowing the blood to clot at room temperature and centrifuged at 2000 rpm for 10 minutes. The sera were transferred into cryovials using clean Pasteur pipettes and stored at -20 &#38;deg;C until required for further analysis.
</p>
<p>
	Detection of human anti-cytomegalovirus IgG using enzyme linked immunosorbent assay (ELISA)
	
	All patients&#38;rsquo; sera were tested for anti-CMV IgM using commercially available ELISA kits (Diagnostic Automation, USA). The procedure was carried out according to manufacturer&#38;rsquo;s instructions. Briefly, 1:40 dilutions were prepared by adding 5 &#38;mu;L of the test samples, negative control, positive control, and calibrators to 200 &#38;micro;L of sample diluent. It was mixed well. Hundred microliter (100 &#38;mu;L) of diluted sera, calibrator, and controls were dispensed into appropriate wells. Hundred microliter (100 &#38;mu;L) of sample diluent was added to the reagent blank well. The plate was incubated at room temperature for 30 minutes. The liquid was removed from all wells by decanting. This was followed by washing the wells with washing buffer and the washing was repeated three times. Hundred microliter (100 &#38;mu;L) of enzyme conjugate was added to each well and incubated for 30 minutes at room temperature. Enzyme conjugate was removed from all wells by decanting and washing was repeated three times with washing buffer. Hundred microliter (100 &#38;mu;L) of tetramethylbenzidine (TMB) chromogenic substrate was added to each well and incubated for 15 minutes at room temperature. This was followed by adding 100 &#38;mu;L of stop solution to stop the reaction. The optical density of each well was read at 450 nm with a microwell reader and interpreted. Samples having CMV G index &#38;ge; 1 were considered positive while those with CMV G index &#38;le; 0.9 were considered negative.
</p>
<p>
	Data analysis
	
	Odds ratio and Chi-square were used at 95% confidence interval to determine association and significant difference between the variables respectively. P-values &#38;le; 0.05 were considered as statistically significant.
</p></Methodology>
<Results>
<p>
	
	
	The overall seroprevalence of Human Cytomegalovirus was 94.3% (Figure 1). Out of the 228 patients examined in the three study hospitals, 215(94.3) were positive for anti-CMV IgM. The highest seroprevalence was observed in HGSGH with 100% (Table 1). Female patients in age-group 15-24 years, those with secondary level of education, those living in the urban areas, the civil servants and the middle class patients had the highest seroprevalence with 98.8%, 98%, 95%, 100% and 94.9% respectively (Table 2). The highest seroprevalence was observed in non-pregnant women (95.2%), pregnant women in their second trimester of pregnancy (95.1%), those with no child and one child (100%), women who had no history of miscarriage (94.7%), those with history of still-birth (100%), women with history of premature delivery (95.2%) and those without disabled child (94.2%) (Table 3). Patients having no sex partners, those with history of blood transfusion, women who do not wash their hands after changing baby&#38;rsquo;s diaper, those who wash their hands after coming in contact with children&#38;rsquo;s urine and those in close contact with children had higher seroprevalence with 100%, 96.7%, 95.5%, 94.7%, 94.4% respectively (Table 4).
</p>
<p>
	Figure 1: Overall seroprevalence of Human Cytomegalovirus. View Figure 1
</p>
<p>
	Table 1: Distribution of Human Cytomegalovirus in relation to study hospitals. View Table 1
</p>
<p>
	Table 2: Seroprevalence of Human Cytomegalovirus with respect to socio-demographic factors. View Table 2
</p>
<p>
	Table 3: Seroprevalence of Human Cytomegalovirus with respect to reproductive history. View Table 3
</p>
<p>
	Table 4: Seroprevalence of Human Cytomegalovirus with respect to risk factors. View Table 4
</p></Results>
<Discussion>
<p>
	
	
	A seroprevalence of 94.3% was obtained for anti-CMV IgM among women of reproductive age attending selected hospitals in Kaduna State, Nigeria. Our finding is similar to 94.3% IgM seroprevalence reported by Nahla, et al. [19] among neonates in Sudan. The high IgM seroprevalence observed in the study is a suggestion that an epidemic might have occurred during the time of the study. As symptoms of Human Cytomegalovirus infections mimic those of other viral infections, the outbreak might have gone unnoticed particularly in developing countries like Nigeria where outbreaks may not always be recognized.
</p>
<p>
	Since studies have demonstrated high congenital Human Cytomegalovirus infections in population with high seroprevalence, the implications of this finding is that there may be a corresponding increase in congenital Human Cytomegalovirus infections among infants in the state. This may lead to rise in HCMV-related hearing and vision loss in children. Maternal HCMV infection is regarded as a predisposing factor for congenital HCMV infection and HCMV-associated hearing loss in children [20].
</p>
<p>
	A sample positive for anti-CMV IgM is not always indicative of recent infection. It may be due to reactivation as a result of the same virus or re-infection with a new or different strain of HCMV. In addition, specific IgM antibody may still be detected for several months or years in low titers after primary infection [21].
</p>
<p>
	However, lower seroprevalences of anti-CMV IgM of 6.0%, 8.9%, 10.5%, 38.5%, 43.6%, 11.8% and 29.3% have been reported in Sudan [22], Kano [23], Kafanchan [24], Ghana [25], Abakaliki [26], Kaduna [27] and Zaria [28] respectively.
</p>
<p>
	In relation to study hospitals, female patients who attended Hajiya Gambo Sawaba General Hospital (HGSGH) had the highest seroprevalence for anti-CMV IgM 100%. This may be as a result of low socioeconomic status and poor hygiene of the women. This is similar to the findings of Yusuf, et al. [28] who observed difference in relation to location.
</p>
<p>
	Women in age group 15-24 years had the highest IgM seroprevalence which is comparable to the findings of Aliyu, et al. [27] who reported highest seroprevalence among women between 16-20 years. The findings contradicts the reports of Khairi, et al. [22], Pathmavathy, et al. [29] and Yusuf, et al. [28] who observed highest seroprevalence among &#38;ge; 40 years, 25-30 years and 21-30 years respectively. Most of the women in that age group are married and it may be as a result of increased sexual activity.
</p>
<p>
	Women who had no congenitally infected child had higher seroprevalence than those with congenitally infected child. This shows that the child&#38;rsquo;s anomaly could be as a result of other agents responsible for congenital abnormalities.
</p></Discussion>
<Conclusion-and-Recommendation>
<p>
	
	
	A seroprevalence of 94.3% was obtained for anti-CMV IgM among women of reproductive age attending selected hospitals in Kaduna State, Nigeria. Women in age group 15-24 years had the highest seroprevalence. Female patients should be educated on the transmission routes as well as preventive measures of cytomegalovirus infections.
</p></Conclusion-and-Recommendation>
<Acknowledgements>
<p>
	
	
	The authors declare no conflicts of interest.
</p></Acknowledgements>
<Contribution-of-Authors>
<p>
	
	
	Anchau, Z.G.: Study design, literature search, data aquisation, data analysis, manuscript preparation; Suleiman, A.B.: Study design, manuscript editing, manuscript review; Olonitola, O.S.: Study design, manuscript editing, manuscript review; Kwanashie, C.N.: Study design, manuscript editing, manuscript review.
</p></Contribution-of-Authors>
<p>
	&#38;nbsp;
</p>



</article-content>

<article-references>
<title>References</title>

		 
<ref id="ref1">
    <label>Reference-1</label>
    <mixed-citation>
					Goldenberg RL, McClure EM, Saleem S, Reddy UM (2010) Infection-related stillbirths. Lancet 375: 1482-1490.
				    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893931/
    </mixed-citation>
</ref>
<ref id="ref2">
    <label>Reference-2</label>
    <mixed-citation>
					Sezgin E, An P, Winkler CA (2019) Host genetics of cytomegalovirus pathogenesis. Front Genet 10: 616.
				    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664682/
    </mixed-citation>
</ref>
<ref id="ref3">
    <label>Reference-3</label>
    <mixed-citation>
					Kadambari S, Pollard AJ, Goldacre MJ, Goldacre R (2020) Congenital viral infections in England over five decades: A population-based observational study. Lancet Infect Dis 20: 220-229.
				    https://pubmed.ncbi.nlm.nih.gov/31708420/
    </mixed-citation>
</ref>
<ref id="ref4">
    <label>Reference-4</label>
    <mixed-citation>
					Parlak M, &#38;Ccedil;im N, Nal&#38;ccedil;a EB, G&#38;uuml;ven A, Bayram Y, et al. (2015) Seroprevalence of Toxoplasma, Rubella, and Cytomegalovirus among pregnant women in Van. Turk J Obstet Gynecol 12: 79-82.
				    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558381/
    </mixed-citation>
</ref>
<ref id="ref5">
    <label>Reference-5</label>
    <mixed-citation>
				Sharma S, Duggal N, Agarwal S, Mahajan RK, Anuradha HC (2015) Seroprevalence of Toxoplasma Rubella and CMV infections in antenatal women in a tertiary care hospital in North India. Journal of Community Diseases 47: 23-26.
				    #
    </mixed-citation>
</ref>
<ref id="ref6">
    <label>Reference-6</label>
    <mixed-citation>
					Nigro G, Anceschi MM, Cosmi EV, Congenital Cytomegalic Disease Collaborating Group (2003) Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection. BJOG 110: 572-577.
				    https://pubmed.ncbi.nlm.nih.gov/12798474/
    </mixed-citation>
</ref>
<ref id="ref7">
    <label>Reference-7</label>
    <mixed-citation>
					Fowler KB, Stagno S, Pass RF (2003) Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 289: 1008-1011.
				    https://pubmed.ncbi.nlm.nih.gov/12597753/
    </mixed-citation>
</ref>
<ref id="ref8">
    <label>Reference-8</label>
    <mixed-citation>
					Lantos PM, Hoffman K, Permar SR, Jackson P, Hughes BL, et al. (2017) Geographic disparities in cytomegalovirus infection during pregnancy. J Pediatric Infect Dis Soc 6: e55-e61.
				    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907865/
    </mixed-citation>
</ref>
<ref id="ref9">
    <label>Reference-9</label>
    <mixed-citation>
					Pereira L, Maidji E, McDonagh S, Tabata TY (2006) Routes of human CMV transmission and infection at the uterine-placental interface. In: Reddehase MJ, Cytomegaloviruses: Molecular Biology and Immunology, Caister Academic Press, Norfolk, 29-48.
				    https://www.caister.com/hsp/abstracts/cmv/02.html
    </mixed-citation>
</ref>
<ref id="ref10">
    <label>Reference-10</label>
    <mixed-citation>
					LeGoff J, P&#38;eacute;r&#38;eacute; H, B&#38;eacute;lec L (2014) Diagnosis of genital herpes simplex virus infection in the clinical laboratory. Virol J 11: 83.
				    https://pubmed.ncbi.nlm.nih.gov/24885431/
    </mixed-citation>
</ref>
<ref id="ref11">
    <label>Reference-11</label>
    <mixed-citation>
					Papaloukas O, Giannouli G, Papaevangelou V (2014) Successes and challenges in varicella vaccine. Ther Adv Vaccines 2: 39-55.
				    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991154/
    </mixed-citation>
</ref>
<ref id="ref12">
    <label>Reference-12</label>
    <mixed-citation>
					Karita HCS, Moss NJ, Laschansky E, Drolette L, Magaret AS, et al. (2017) Invasive obstetric procedures and cesarean sections in women with known herpes simplex virus status during pregnancy. Open Forum Infect Dis 4: ofx248.
				    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751035/
    </mixed-citation>
</ref>
<ref id="ref13">
    <label>Reference-13</label>
    <mixed-citation>
					Fowler KB, Pass RF (2006) Risk factors for congenital cytomegalovirus infection in the offspring of young women: Exposure to young children and recent onset of sexual activity. Paediatrics 118: e286-292.
				    https://pubmed.ncbi.nlm.nih.gov/16847076/
    </mixed-citation>
</ref>
<ref id="ref14">
    <label>Reference-14</label>
    <mixed-citation>
					Griffiths P, Baraniak I, Reeves M (2015) The pathogenesis of human cytomegalovirus. J Pathol 235: 288-297.
				    https://pubmed.ncbi.nlm.nih.gov/25205255/
    </mixed-citation>
</ref>
<ref id="ref15">
    <label>Reference-15</label>
    <mixed-citation>
				Naing L, Winn T, Rusli BN (2006) Practical issues in calculating the sample size for prevalence studies. Archives of Orofacial Sciences 1: 9-14.
				    #
    </mixed-citation>
</ref>
<ref id="ref16">
    <label>Reference-16</label>
    <mixed-citation>
					Wang C, Dollard SC, Amin MM, Bialek SR (2016) Cytomegalovirus IgM seroprevalence among women of reproductive age in the United States. PLoS One 11: e0151996.
				    https://pubmed.ncbi.nlm.nih.gov/26990759/
    </mixed-citation>
</ref>
<ref id="ref17">
    <label>Reference-17</label>
    <mixed-citation>
					Yeroh M, Aminu M, Musa BOP (2015) Seroprevalence of cytomegalovirus infection amongst pregnant women in Kaduna state, Nigeria. African Journal of Clinical and Experimental Microbiology 16: 37-44.
				    https://www.ajol.info/index.php/ajcem/article/view/110734
    </mixed-citation>
</ref>
<ref id="ref18">
    <label>Reference-18</label>
    <mixed-citation>
				Umeh EU, Onoja TO, Aguoru CU, Umeh JC (2015) Seroprevalence of cytomegalovirus antibodies in pregnant women, Benue State, Nigeria. Journal of Infectious Disease and Therapy 3: 242.
				    #
    </mixed-citation>
</ref>
<ref id="ref19">
    <label>Reference-19</label>
    <mixed-citation>
				Nahla KH, Ali YH, Enan KH (2011) Studies on congenital infections in Sudan: Seroprevalence of cytomegalovirus. Journal of Science and Technology 12: 8290.
				    #
    </mixed-citation>
</ref>
<ref id="ref20">
    <label>Reference-20</label>
    <mixed-citation>
					de Vries JJC, Van Zwet EW, Dekker FW, Kroes ACM, Verkerk PH, et al. (2013) The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: A population-based prediction model. Rev Med Virol 23: 241-249.
				    https://pubmed.ncbi.nlm.nih.gov/23559569/
    </mixed-citation>
</ref>
<ref id="ref21">
    <label>Reference-21</label>
    <mixed-citation>
					Sirin MC, Agus N, Yilmaz N, Bayram A, Derici YK, et al. (2017) Seroprevalence of Toxoplasma gondii, Rubella virus and Cytomegalovirus among pregnant women and the importance of avidity assays. Saudi Med J 38: 727-732.
				    https://pubmed.ncbi.nlm.nih.gov/28674718/
    </mixed-citation>
</ref>
<ref id="ref22">
    <label>Reference-22</label>
    <mixed-citation>
				Khairi SI, Intisar KS, Enan KH, Ishag MY, Baraa AM, et al. (2013) Seroprevalence of cytomegalovirus infection among pregnant women at Omdurman Maternity Hospital, Sudan. Journal of Medical Laboratory and Diagnosis 4: 45-49.
				    #
    </mixed-citation>
</ref>
<ref id="ref23">
    <label>Reference-23</label>
    <mixed-citation>
					Hamid KM, Onoja AB, Tofa UA, Garba KN (2014) Seroprevalence of cytomegalovirus among pregnant women attending Murtala Mohammed Specialist Hospital Kano, Nigeria. Afr Health Sci 14: 125-130.
				    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449078/
    </mixed-citation>
</ref>
<ref id="ref24">
    <label>Reference-24</label>
    <mixed-citation>
				Deborah SE, Isaac UE, Nwankiti O, Ishaku BS, Musa MA (2015) Seroprevalence of Cytomegalovirus (IgM) antibodies among pregnant women attending antenatal clinic at the General hospital Kafanchan, Kaduna State, Nigeria. British Microbiology Research Journal 9: 1-6.
				    #
    </mixed-citation>
</ref>
<ref id="ref25">
    <label>Reference-25</label>
    <mixed-citation>
					Kwofie TB, Ayensu F, Mutocheluh M, Narkwa P, Nguah SB, et al. (2015) Seroprevalence of Rubella virus, Cytomegalovirus and Herpes Simplex Virus-2 among pregnant women at the Komfo Anokye Teaching Hospital, Ghana. JPHDC 1: 56-63.
				    https://www.jphdc.org/index.php/jphdc/article/view/14
    </mixed-citation>
</ref>
<ref id="ref26">
    <label>Reference-26</label>
    <mixed-citation>
				Anuma ON, Umeora OUJ (2016) Seroprevalence of cytomegalovirus antibodies among antenatal clinic attendees in Abakaliki, Nigeria. African Journal of Medical Health 15: 24-29.
				    #
    </mixed-citation>
</ref>
<ref id="ref27">
    <label>Reference-27</label>
    <mixed-citation>
				Aliyu A, Aminu M, Olonitola OS, Umar M, Tahir MI (2016) Seroprevalence and molecular detection of Human Cytomegalovirus in HIV positive patients attending some selected hospitals in Kaduna State, Nigeria. Journal of Advances in Biology and Biotechnology 9: 1-22.
				    #
    </mixed-citation>
</ref>
<ref id="ref28">
    <label>Reference-28</label>
    <mixed-citation>
					Yusuf IT, Olonitola OS, Jatau ED (2018) Seroprevalence of Cytomegalovirus among women of reproductive age attending selected hospitals in zaria metropolis, Kaduna State, Nigeria. International Journal of scientific Research Publication 8.
				    https://www.ijsrp.org/research-paper-1218.php?rp=P848051
    </mixed-citation>
</ref>
<ref id="ref29">
    <label>Reference-29</label>
    <mixed-citation>
				Padmavathy M, Gowri M, Malini J, Umapathy BL, Navaneeth BV, et al. (2013) Seroprevalence of TORCH infections and adverse reproductive outcome in current pregnancy with bad obstetric history. J Clin Biomed Sci 3.
				    #
    </mixed-citation>
</ref>



</article-references>
</body>
</article>